Elixinol appoints Tom Siciliano as new CEO Americas

Elixinol, a global hemp derived CBD brand, announced it has named Tom Siciliano as the organization’s new CEO Americas effective immediately. Siciliano is charged with leading Elixinol’s refined strategy on hemp derived CBD in the Americas region.

“We are delighted to appoint a leader with Tom’s strategic, financial, operational and sales experience,” said Stratos Karousos, Elixinol Group CEO. “Elixinol, like the rest of the world, is currently navigating uncertain times. We are confident in Tom’s leadership and ability to drive growth, including through our rebranded health and wellness products, while also helping to execute on our commitment to provide shareholders a return on investment.”

Prior to this, Siciliano was president of Nutritional High International Inc. a vertically integrated cannabis manufacturing and distribution company with operations in Colorado, Oregon, Washington, Nevada and California. Prior to Nutritional High, Siciliano served as President and Chief Financial Officer for Canna Security America where he turned the company into the second largest security company within the cannabis industry.

“I am incredibly excited about the opportunity to join the Elixinol team and work to grow the reach of our CBD products,” Siciliano said. “I believe in this industry and the importance cannabis plays in health and wellness and our regional economy.”

Siciliano has served as senior executive in various startup companies, private equity firms and public Fortune 500 companies where he successfully orchestrated several turnaround results.

Siciliano is also a published author and holds a bachelor’s degree in Business Administration from Columbus University.

Website | + posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: